N
Nelson B. Watts
Researcher at University of Cincinnati Academic Health Center
Publications - 215
Citations - 20940
Nelson B. Watts is an academic researcher from University of Cincinnati Academic Health Center. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 59, co-authored 209 publications receiving 18999 citations. Previous affiliations of Nelson B. Watts include Emory University & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.
Steven R. Goldstein,Susan R. Johnson,Nelson B. Watts,Angelina V. Ciaccia,Derek Elmerick,David Muram +5 more
TL;DR: In this article, the effect of raloxifene or estrogen on reporting of urinary incontinence in postmenopausal women participating in an osteoporosis prevention trial was investigated.
Journal ArticleDOI
Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
Bruce R. Carr,Elizabeth A. Stewart,David F. Archer,Ayman Al-Hendy,Linda D. Bradley,Nelson B. Watts,Michael P. Diamond,Jingjing Gao,Charlotte D. Owens,Kristof Chwalisz,W. Rachel Duan,Ahmed M. Soliman,Matthew B. Dufek,James A. Simon +13 more
TL;DR: In this paper, the authors evaluated elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding associated with uterine leiomyomas.
Journal ArticleDOI
Short Sleep Is Associated With Low Bone Mineral Density and Osteoporosis in the Women's Health Initiative.
Heather M. Ochs-Balcom,Kathleen M. Hovey,Chris Andrews,Jane A. Cauley,Lauren Hale,Wenjun Li,Jennifer W. Bea,Gloria E. Sarto,Marcia L. Stefanick,Katie L. Stone,Katie L. Stone,Nelson B. Watts,Oleg Zaslavsky,Jean Wactawski-Wende +13 more
TL;DR: Short sleep duration was associated with lower BMD and higher risk of osteoporosis, and associations of sleep quality and DXA BMD failed to reach statistical significance.
Journal ArticleDOI
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
Hugh S. Taylor,Linda C. Giudice,Bruce A. Lessey,Mauricio Simões Abrão,J. Kotarski,David F. Archer,Michael P. Diamond,Eric S. Surrey,Neil P. Johnson,Nelson B. Watts,J. C. Gallagher,James A. Simon,Bruce R. Carr,W. P. Dmowski,Nicholas Leyland,J.P. Rowan,W.R. Duan,Juki Ng,B. Schwefel,Jacqueline Thomas,Rita Jain,Kristof Chwalisz +21 more
TL;DR: In this paper, the effects of two doses of elagolix (150 mg once daily and 200 mg twice daily) compared with placebo in women with surgically diagnosed endometriosis and moderate or severe pain were evaluated.
Journal ArticleDOI
Denosumab in osteoporosis
Dima L. Diab,Nelson B. Watts +1 more
TL;DR: Denosumab could be used as initial therapy in select patients at high risk for fracture, including older patients who have difficulty with the dosing requirements of oral bisphosphonates, patients who are intolerant of or unresponsive to other therapies, and in those with impaired renal function.